Evidence map›Paper›PMID 34780682›Full record

Observational studyImmunity, inflammation and disease2022

Association of serum surfactant protein D and SFTPD gene variants with asthma in Danish children, adolescents, and young adults.

Benjamin Hoffmann-Petersen, Raymond Suffolk, Jens J H Petersen, Thomas H Petersen, Charlotte Brasch-Andersen, Arne Høst, Susanne Halken, Grith L Sorensen, Lone Agertoft

Open access · goldAbstract readObservational Study
In one paragraph

Observational study in Immunity, inflammation and disease, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 1 pooled it
0.6field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 1 synthesis or guideline pooled it, 7 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Observational
  5. Article
  6. Article
  7. Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 5 institutions in 1 country.

Benjamin Hoffmann-PetersenHans Christian Andersen Children's Hospital, Odense University Hospital, Odense, Denmark.ORCID 0000-0002-6259-6802
Raymond SuffolkDepartment of Pediatrics, Hospital of Southern Jutland, Aabenraa, Denmark.
Jens J H PetersenDepartment of Pediatrics, Hospital of Southern Jutland, Esbjerg, Denmark.
Thomas H PetersenDepartment of Pediatrics, Hospital of Southern Jutland, Kolding, Denmark.ORCID 0000-0001-7951-6031
Charlotte Brasch-AndersenDepartment of Clinical Genetics, Odense University Hospital, Odense, Denmark.ORCID 0000-0003-4273-0047
Arne HøstHans Christian Andersen Children's Hospital, Odense University Hospital, Odense, Denmark.ORCID 0000-0001-8346-4860
Susanne HalkenHans Christian Andersen Children's Hospital, Odense University Hospital, Odense, Denmark.ORCID 0000-0003-0161-8278
Grith L SorensenInstitute of Molecular Medicine, University of Southern Denmark, Odense, Denmark.ORCID 0000-0002-5273-1097
Lone AgertoftHans Christian Andersen Children's Hospital, Odense University Hospital, Odense, Denmark.ORCID 0000-0001-6840-7921
Odense University Hospital · DKUniversity of Southern Denmark · DKHospital South West Jutland · DKKolding Hospital · DKSygehus Sønderjylland · DK

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundSurfactant Protein D (SP-D) is a pattern recognition molecule belonging to the family of collectins expressed in multiple human organ systems, including the lungs. Previous studies have shown that SP-D levels in bronchoalveolar lavage samples decrease and serum levels increase in patients suffering from asthma, possibly due to a combination of induced SP-D synthesis and decreased air-blood barrier integrity. The aims of this study were to investigate whether serum levels of SP-D and common variants in the SP-D gene were associated with asthma in adolescents and young adults.

methodsProspective observational study including 449 adolescents and young adults (age 11-27 years) previously diagnosed with asthma during a 2-year period from 2003 to 2005 (0-16 years). At follow-up from 2016 to 2017, 314 healthy controls with no history of asthma were recruited. Serum SP-D was analyzed on samples obtained at baseline as well as samples obtained at follow-up. SP-D genotyping was performed for rs721917, rs2243639, and rs3088308.

resultsNo differences were found in mean levels of sSP-D and SFTPD genotype among subjects with current asthma, no current asthma, and controls. Serum SP-D and SFTPD genotype were not associated with any clinical parameters of asthma. Furthermore, baseline sSP-D was not associated with asthma at follow-up.

conclusionSerum surfactant protein D and common SP-D gene variants were not associated with asthma in Danish adolescents and young adults with mild to moderate asthma. Serum surfactant protein D did not demonstrate any value as a clinical biomarker of asthma.

Indexed as

AsthmaPulmonary Surfactant-Associated Protein DAdolescentAdultChildDenmarkGenotypeHumansLungYoung AdultPulmonary Surfactant-Associated Protein Dadolescentasthmabiomarkerchildsurfactant protein D

Identifiers

PMID34780682
PMCPMC8767520
OpenAlexW3212315750

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.